eFFECTOR Therapeutics, Inc.
EFTR
$0.0002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.83M | -9.13M | -8.30M | -8.36M | -10.01M |
| Total Depreciation and Amortization | 28.00K | 30.00K | 26.00K | 27.00K | 28.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.05M | 1.11M | 1.04M | 1.18M | 1.14M |
| Change in Net Operating Assets | 479.00K | 2.43M | -521.00K | -1.43M | 1.21M |
| Cash from Operations | -7.28M | -5.57M | -7.76M | -8.59M | -7.64M |
| Capital Expenditure | -- | -54.00K | -2.00K | -28.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.32M | 9.00M | -1.91M | -1.55M | 9.04M |
| Cash from Investing | -6.32M | 8.95M | -1.92M | -1.57M | 9.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -556.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 14.79M | 6.11M | 342.00K | 14.57M | 212.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.23M | 6.11M | 342.00K | 14.57M | 212.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 633.00K | 9.49M | -9.33M | 4.40M | 1.60M |